Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Ever get the feeling that:

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Nov 29, 2022 6:16pm

181 Views

Post# 35138096

RE:RE:RE:RE:Ever get the feeling that:

you folks have been blowing smoke or smoking something fir the last 3 years. you said the same thing 3 years ago. I will just wait for official information if and when that comes. if I rubbed my crystal balls i would say we see something positive by mid 2023.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"